Atlas Trials

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

Clinical trial NCT03546686 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03546686
Sponsor
University of Texas Southwestern Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2019-11-12
Primary completion
2027-06-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.